BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseas...
How might the reported results influence shortâterm technical indicators and trading volume for BCDA?
What were the market reactions during the conference call Q&A, and were there any redâflag concerns raised by analysts?
Were there any notable changes in the capital structure, such as share issuances, debt financing, or stock option activity?
15 days ago